About Hakodate Municipal Hospital
Clinical Trials at Hakodate Municipal Hospital
During the past decade, Hakodate Municipal Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hakodate Municipal Hospital" #1 sponsor was "Amgen" with 1 trials, followed by "Boston Scientific Corporation" with 1 trials
sponsored, "Cook Group Incorporated" with 1 trials sponsored, "Medtronic Vascular" with 1 trials sponsored and "OrbusNeich"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hakodate Municipal Hospital"
#1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Medtronic Japan Co., Ltd." with 1 trials as a collaborator and "OrbusNeich Medical K.K." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Hakodate Municipal Hospital
According to Clinical.Site data, the most researched conditions in "Hakodate Municipal Hospital" are
"Coronary Artery Disease" (2 trials), "Aortic Dissection" (1 trials), "Arterial Occlusive Diseases" (1 trials), "Atherosclerosis" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Hakodate Municipal Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Hakodate Municipal Hospital
Most popular intervention types in "Hakodate Municipal Hospital" are "Device" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Everolimus Eluting Stent (EES)" (1 trials), "Lp(a) Screening" (1 trials), "MDT-4107 Drug Eluting Stent" (1 trials), "OrbusNeich Combo stent™" (1 trials) and "PROMUS Element" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hakodate Municipal Hospital
The vast majority of trials in "Hakodate Municipal Hospital" are
5 trials for "All" genders.
Clinical Trials Status at Hakodate Municipal Hospital
Currently, there are NaN active trials in "Hakodate Municipal Hospital".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hakodate Municipal Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hakodate Municipal Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".